- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics - Abstract
November 12, 2012
M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer - Abstract
November 10, 2012
Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells - Abstract
November 10, 2012
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo - Abstract
November 9, 2012
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer - Abstract
November 9, 2012
Inflammation-mediated abrogation of androgen signaling: An in vitro model of prostate cell inflammation - Abstract
November 9, 2012
Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span - Abstract
November 8, 2012
Anterior gradient 2 (AGR2): Blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype - Abstract
November 8, 2012
Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction - Abstract
November 7, 2012
The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells - Abstract
November 7, 2012
Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma - Abstract
November 7, 2012
Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma - Abstract
November 7, 2012